Background of the present study was to assess the usefulness of double phase positron emission tomography/computed tomography (peT/CT) to differentiate malignant from benign pulmonary lesions with low fluorine-18 fluorodeoxyglucose (F-18 FDG) uptake.
F-18 FDG peT is a noninvasive modality that has been widely used for differentiation of malignant from benign pulmonary lesions [1] [2] [3] [4] . several studies have demonstrated that F-18 FDG peT can reduce the number of patients with pulmonary nodules who undergo unnecessary surgical biopsy [5] [6] [7] . a threshold of standardized uptake value (sUV) of 2.5 has been proposed as the optimal criteria for differentiating malignant from benign lung nodules [8, 9] . However, there is considerable overlap between the levels of FDG uptake of malignant and benign lesions. Recent study reported that the sensitivity of sUV cutoff value of 2.5 was lower than that of visual analysis for differentiating malignant lung nodules and this criterion of sUV 2.5 is inappropriate especially in low F-18 FDG uptake lung nodules [10] .
Factor such as body habitus, timing of imaging after FDG injection, and plasma glucose level are important factors that doi: 10.4149/neo_2009_01_33 influence the image quality and SUV measurement. For example large, rapidly growing, and metabolic active lesions shows intense F-18 FDG uptake. In contrast, slowly growing, well-differentiated, or small lesions exhibit little or no accumulation [11] .
The low FDG uptake of solitary lung lesions face a diagnostic dilemma. Recently, Hashimoto et al. reported that for solid pulmonary lesions with low FDG uptake, semiquantitative approaches did not improve the accuracy of F-18 FDG PET over that obtained with visual analysis [12] .
Recently, to better distinguish benign lesion from malignant diseases, some studies have made major findings using dual phase acquisition of F-18 FDG and other radiopharmaceuticals with PET [12] [13] [14] [15] [16] [17] . However, very few study adopted the dual phase acquisition of F-18 FDG PET for the evaluation of pulmonary nodules with low F-18 FDG uptake [18] .
The aim of the present study was to investigate whether double phase F-18 FDG PET/CT could improve the diagnostic accuracy for the evaluation of low metabolic pulmonary lesions and whether quantitative indices could predict malignant nature of these lesions.
Methods
Patients. From May 2005 to June 2006, a total of 218 patients (154 men and 64 women, age range; 25-83 years, mean; 60 years) with focal pulmonary lesions detected by chest computed tomography (CT), underwent integrated PET/CT. Of the 218 patients, we retrospectively enrolled 73 patients who had focal pulmonary lesions with an SUV of <2.5 on F-18 FDG PET/CT.
Of these 73 patients, 43 were excluded because that follow-up imaging study and cytologic or histologic diagnosis were unavailable. Therefore, the final analysis was conducted in 30 patients (male; 18, female; 12, mean age; 56.2 years old, age range; 26-72 years). These patients underwent trans-thoracic needle biopsy (n=10), video-assisted thoracoscopic surgery (n=1), and lobectomy (n=6). Thirteen patients, in whom CT and clinical findings suggested benignancy but in whom histopathologic diagnosis was not obtained, were regarded to have benign lesion, because lesions showed no change (n = 10) or a reduction (n = 3) in size at CT follow-up. Lesions without size change were followed up at least once or more by CT studies for more than 12 months (mean; 17.4±3.8 months, range; 12~23 months).
Chest computed tomography. Chest CT scans were available in all 30 patients. Chest CT was performed using a four (LightSpeed QX/i scanner; GE Medical Systems, Milwaukee, WI) or 16-(Sensation 16; Siemens, Germany) row multi-detector CT (MDCT). One radiologist with 4-year experience of chest CT reviewed all CT scans and evaluated morphologic features of pulmonary lesions including margin and presence or absence of a satellite lesion. Margins were classified as smooth, lobulated, or spiculated. Long-axis diameters of lesions were also measured.
F-18 FDG PET/
CT. An F-18 FDG PET/CT image was done with a dedicated PET/CT scanner (Gemini, Philips, Milpitas, CA, USA), consisting of a dedicated germanium oxyorthosilicate fullring PET scanner and a dual slice helical CT scanner. Standard patient preparation included at least 8 hours fasting and a serum glucose level of less than 140 mg/dL before F-18 FDG administration. PET/CT imaging was performed 60 and 120 minutes after injection of F-18 FDG (mean dose, 383.7±47.4 MBq; range, 314.5~488.4 MBq). At 60 minutes (early images) after administration of F-18 FDG, low-dose CT (30 mAs, 120kV) covering area from the base of the skull to the proximal thighs was performed for the purpose of attenuation correction and precise anatomical localization. Thereafter, emission scan was conducted in the 3-dimensional mode. Emission scan time per bed position was 3 minutes; 9 bed positions were acquired. Delayed PET emission images of the chest were acquired at 120 min after administration of F-18 FDG, using 2 or 3 bed positions with a 3-min acquisition at each. This acquisition was immediately followed by a transmission scan of the same transverse planes, using a 2-min acquisition at each bed position. PET data were obtained using a high resolution whole body scanner with an axial field of view of 18 cm. The average axial resolution varied between 4.2 mm full width at half maximum (FWHM) in the center and 5.6 mm at 10 cm. The average total PET/CT examination time was 30 minutes. After scatter and decay correction, PET data were reconstructed iteratively with attenuation correction and reoriented in axial, sagittal, and coronal slices. The row action maximum-likelihood algorithm was used for 3-dimensional reconstruction.
F-18 FDG PET/CT image analysis.
PET/CT data sets of early and delayed scans were evaluated by two nuclear medicine physicians, respectively blinded to all CT, clinical, and pathological results. Decisions concerning the analysis of F-18 FDG PET/CT data sets were reached by consensus. The intensity of F-18 FDG uptake by pulmonary lesions relative to the background activity in the uninvolved adjacent lung parenchyma and the mediastinum was assessed visually, and the intensity was scored with a 4-point scale (Grade 1; absent, Grade 2; faint, Grade 3; moderate, Grade 4; intense) as reported previously [19] . Also, PET/CT data sets of early and delayed images were analyzed quantitatively by use of the SUV and the contrast ratio (CR) as indices of F-18 FDG uptake. Spherical regions of interest (ROIs) were placed over lesions visible on PET images. The ROIs of lesions that were invisible on PET images were located by use of the corresponding CT images. ROIs were placed in the same area on the selected image for both of early and delayed images. The maximal SUV of early images (SUV max1 ) and delayed images (SUV max2 ) were calculated by manually drawing a region of interest (ROI) over the most intense slice of primary lesion visible on early and delayed PET images. The CR was determined by measuring the highest activity in the tumor ROI (T) and in the contralateral normal lung ROI (N) and was calculated as (T-N)/(T+N) for early image (CR 1 ) and delayed images (CR 2 ) as previously described [20] . From these quantitative 35 
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indices, the % change of SUVmax and % change of CR were calculated as following equations:
% change of SUVmax (%∆SUV max )= (SUV max2 -SUV max1 )/ SUV max1 X 100 % change of CR (%∆CR)=(CR 2 -CR 1 )/CR 1 X 100 Statistical Analysis. Statistical analyses were performed using commercially available software (MedCalc 9.3, Mariakerke, Belgium). Receiver-operating-characteristic (ROC) curves for each parameter were derived and evaluated by comparing the areas under the curves. The sensitivity and specificity of each parameter were determined at the optimal cutoff values by ROC curve analyses. The Chi-square test, Fisher's exact test, and Mann-Whitney test were used to analyze statistical differences in morphologic features and long-axis diameter of lesions on CT, SUV max1 , SUV max2 , %∆SUV max , CR1, CR2, and %∆CR between malignant and benign pulmonary lesions. Agreement between observer 1 and observer 2 for visual assessment of double phase F-18 FDG PET scan was assessed by means of Cohen kappa statistic and its standard error. The interpretation of the κ is such that κ greater than 0.75 is regarded as excellent agreement, κ greater than 0.40 as good agreement, and κ less than 0.40 as marginal agreement of observer 1 and observer 2. Statistical significance was defined as p<0.05.
Results

Lesion Characteristics at Pathology and CT.
Of 30 nodules, 13 (43%) proved to be malignant and 17 (57%) benign (Table 1 ). Of 13 malignant lesions, 11 were histologically confirmed primary lung cancers (8 adenocarcinomas, 2 squamous cell carcinomas, and 1 small cell lung cancer) and two were metastastic lung cancers (1 metastatic adenocarcinoma from colon cancer and 1 metastatic adenoid cystic carcinoma). Four of 17 benign lesions were histologically confirmed (1 tuberculoma, 1 aspergillosis, 1 acute inflammation, and 1 chronic inflammation) ( Table 1) .
The maximum diameters were not significantly different between malignant (19.0 ± 7.2, range; 8.9~29.4 mm) and benign (21.3 ± 9.9, range; 10.4~42.0 mm) lesions ( Table 2 shows the results of ROC analyses of visual and quantitative indices of double phase F-18 FDG PET/CT for differentiation between malignant and benign pulmonary lesions. The optimal visual grade was>grade 2. When> grade 2 was used as cut-off value, the sensitivity and specificity were 46.1% and 82.3%, respectively. The positive and negative predictive values were 66.7% and 66.7%, respectively. The AUC was 0.658 (95% CI, 0.464-0.820) and standard error (SE) was 0.103.
The optimal SUV max1 was >2. When SUV max1 was >2 was used as cut off point, the sensitivity and specificity were 46.1% and 82.3%, respectively. The positive and negative predictive values were 66.7% and 66.7%, respectively. The AUC was 0.785 (95% CI, 0.597-0.913) and SE was 0.088. The optimal SUV max2 was >1.81. When SUV max2 was >1.81 was used as cut off point, the sensitivity and specificity were 69.2% and 94.1%, respectively. The positive and negative predictive values were 90% and 80%, respectively. The AUC was 0.848 (95% CI, 0.671-0.952) and SE was 0.076. The optimal %∆SUV max was >-2.3%. When %∆SUV max was >-2.3% was used as cut off point, the sensitivity and specificity were 92.3% and 70.5%, respectively. The positive and negative predictive values were 70.6% and 92.3%, respectively. The AUC was 0.846 (95% CI, 0.668-0.950) and SE was 0.076. The optimal CR 1 was >0.68. When CR 1 was >0.68 was used as cut off point, the sensitivity and specificity were 76.9% and 70.5%, respectively. The positive and negative predictive values were 66.7% and 80%, respectively. The AUC was 0.801 (95% CI, 0.615-0.923) and SE was 0.085. The optimal CR 2 was >0.58. When SUV max2 was >0.58 was used as cut off point, the sensitivity and specificity were 100% and 70.5%, respectively. The positive and negative predictive values were 72.2% and 100%, respectively. The AUC was 0.842 (95% CI, 0.662-0.948) and SE was 0.077. The optimal %∆CR was >-1.7%. When %∆CR was >-1.7% was used as cut off point, the sensitivity and specificity were 92.3% and 41.1%, respectively. The positive and negative predictive values were 54.5% and 87.5%, respectively. The AUC was 0.511 (95% CI, 0.323-0.697) and SE was 0.108.
Comparison of quantitative indices between malignant and benign lesions. Figure 1 reveals the differences of quantitative indices of double phase F-18 FDG PET/CT of malignant and benign pulmonary lesions. The SUV max1 of malignant pulmonary lesion was significantly higher than that of benign one (1.82±0.57 vs 1.16±0.58, p=<0.0084). Also, SUV max2 of malignant pulmonary lesion was significantly higher than that of benign one (2.01±0.59 vs 1.08±0.58, p=0.0013). The %∆SUV max of malignant pulmonary lesion was significantly higher than that of benign one (11.9±12.9% vs -7.3±15.1, p=0.0014). The CR 1 of malignant pulmonary lesion was significantly higher than that of benign one (0.72±0.09 vs 0.53±0.2, p=0.0054). Also, CR 2 of malignant pulmonary lesion was significantly higher than that of benign one (0.76±0.07 vs 0.53±0.17, p=0.0016). However, %∆CR revealed no statistical differences (5.9±8.8% vs 8.3±30.9, p=0.9167). Table 3 showed the results of pairwise comparison of ROC analysis of quantitative indices and vi- Among the quantitative indices, SUV max1 , SUV max2 , and CR 2 were superior to the visual analysis for differentiation of malignant from benign pulmonary lesions. The SUV max1 , SUV max2 , and %∆SUV max were superior to %∆CR for differentiation of malignant from benign pulmonary lesions. Table 4 revealed that agreement for visual analysis of double phase F-18 FDG PET/CT was good for differentiation of malignant from benign pulmonary lesions (weighted κ=0.701).
Comparison of ROC curve of quantitative indices and visual analysis.
Inter-observer agreements of visual analysis of double phase F-18 FDG PET/CT.
Discussion
The major contribution of the present study was that the visual analysis and quantitative analysis of double phase F-18 FDG PET/CT could differentiate malignant from benign pulmonary lesions with low F-18 FDG uptake similarly.
The single-time-point SUV of 2.5~3.8 has been cited as the optimal cut-off value in pulmonary lesions for diagnosing lung cancer [8] . Most inflammatory lesions would fall below this cut-off value, whereas the majority of malignant lesions would have higher SUVs.
Because the uptake of F-18 FDG in malignancies is expected to increase over time, the initial inclination would be to perform a single scan at a time point later than the usual 45-60 min. In theory, this strategy should lead to improved contrast between lesion and background and improved diagnostic accuracy, making dual-time-point scanning unnecessary. However, although this strategy may improve sensitivity, specificity may remain low because of the overall low F-18 FDG uptake of these lesions.
In the current study, delayed quantitative indices (SUV max2 and CR 2 ) showed an increase of sensitivity from 8% to 23% without decline of specificity for differentiation of malignant from benign pulmonary lesions. However, the other quantitative indices such as %∆SUV max and %∆CR showed high sensitivities with low specificities. Therefore, we believe that changes in dual-time-point SUVs would be a more valuable diagnostic tool than imaging at early or delayed single time point alone.
Recently, similar to the present study, Xiu et al. [18] conducted a study to compare the accuracy of dual-time point and single-time FDG PET imaging in the evaluation of lung nodules with minimally increased metabolic activity. In their study, the lowest diagnostic accuracies came from the visual and single SUV analysis on the initial images and the visual and single SUV analyses on the delayed images produced increased accuracy. Moreover, they found that the highest [5] [6] [7] . However, some benign inflammatory lesions could show F-18 FDG accumulation yielding false positive findings [22] [23] [24] .
Recently, to better distinguish benign lesion from malignant diseases, some studies have made major findings using dual phase acquisition of F-18 FDG and other radiopharmaceuticals with PET [12] [13] [14] [15] [16] [17] . Some studies have demonstrated that malignant disease showed a higher SUV on delayed PET images than on single early point PET images [25, 26] .
The degree of F-18 FDG uptake by malignant lesions is influenced by various factors, including biologic nature and lesion size. Among these factors, tissue differentiation of tumors is important [11] . Most malignant pulmonary nodules with SUVs of <2.5 are differentiated adenocarcinomas [10] . Our study showed that 61.5% of the malignant lesions were determined histologically to be differentiated adenocarcinomas.
The present study compared 6 different quantitative indices of double phase F-18 FDG PET/CT for differentiation of malignant from benign pulmonary lesions. One study has indicated that the CR is more sensitive than the SUV in diagnosing faintly positive pulmonary nodules when the classical SUV criterion of 2.5 is applied [10] . However, the comparison of ROC curve of the present study showed that these quantitative indices were similar in terms of overall diagnostic performance except %∆CR. The %∆CR revealed the lowest diagnostic accuracy for differentiation malignant from benign pulmonary lesions. Also, among the quantitative indices of double phase F-18 FDG PET/CT, the SUV max1 , SUV max2 , and CR 2 were superior to visual assessment for differentiation of malignant from benign pulmonary lesions.
Based on the presented results, the quantitative indices except %∆CR were higher in malignant nodules than benign pulmonary nodules. However, the diagnostic performances were similar between visual and quantitative analyses. Further studies are needed to confirm these results and improve statistical accuracy.
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